Passive Perinatal Immunotherapy via Transamniotic Antibody Delivery

This preclinical study demonstrates that therapeutic antibodies can be successfully delivered to the fetus via intra-amniotic injection, with dose-dependent distribution to neonatal serum and tissues. The research establishes proof-of-concept for transamniotic passive immunization as a potential route for perinatal therapeutic interventions.